|
1 Company |
|
0 Products |
|
0 Products |
|
0 Mechanisms of Action |
|
0 Trials |
|
3 News |
|
- ||||||| Increlex (mecasermin) / Ipsen
Trial completion: Long-Term Treatment With rhIGF-1 in GHIS (clinicaltrials.gov) - Sep 30, 2015
P2/3, N=92, Completed, Sponsor: Ipsen
Active, not recruiting --> Completed
- Trial completion: IGF-I/IGFBP-3 Therapy in Children and Adolescents With Growth Hormone Insenitivity Syndrome (GHIS) Such as Laron Syndrome (clinicaltrials.gov) - Sep 10, 2012
P2/3, N=0, Completed, Sponsor: Insmed
Active, not recruiting --> Completed Active, not recruiting --> Completed
- ||||| Increlex (mecasermin) / Ipsen
Enrollment change: Long-Term Treatment With rhIGF-1 in GHIS (clinicaltrials.gov) - Nov 28, 2011
P2/3, N=92, Active, not recruiting, Sponsor: Ipsen
Active, not recruiting --> Completed N=76 --> 92